Annual Drug Patent Expirations for DORYX+MPC
Doryx Mpc is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for DORYX MPC.
This drug has two patent family members in two countries.
The generic ingredient in DORYX MPC is doxycycline hyclate. Two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com